• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Elise A. Olsen, Eric C Vonderheid, +18 authors Sean Whittaker
  • Medicine
  • Blood
  • 2007 (First Publication: 15 September 2007)
  • The ISCL/EORTC recommends revisions to the Mycosis Fungoides Cooperative Group classification and staging system for cutaneous T-cell lymphoma (CTCL). These revisions are made to incorporate advancesContinue Reading
  • Nancy J. Senff, Evert M. Noordijk, +11 authors Rein Willemze
  • Medicine
  • Blood
  • 2008 (First Publication: 1 September 2008)
  • Primary cutaneous B-cell lymphomas (CBCL) represent approximately 20% to 25% of all primary cutaneous lymphomas. With the advent of the World Health Organization-European Organization for ResearchContinue Reading
  • S J Whittaker, Marie-France Demierre, +10 authors Youn H Kim
  • Medicine
  • Journal of clinical oncology : official journal…
  • 2010 (First Publication: 10 October 2010)
  • PURPOSE The primary objective of this study was to confirm the efficacy of romidepsin in patients with treatment refractory cutaneous T-cell lymphoma (CTCL). PATIENTS AND METHODS ThisContinue Reading
  • Werner Kempf, Katrin Pfaltz, +23 authors Rein Willemze
  • Medicine
  • Blood
  • 2011 (First Publication: 13 October 2011)
  • Primary cutaneous CD30(+) lymphoproliferative disorders (CD30(+) LPDs) are the second most common form of cutaneous T-cell lymphomas and include lymphomatoid papulosis and primary cutaneousContinue Reading
  • Madeleine Duvic, Ann G. Martin, +4 authors Richard C. Yocum
  • Medicine
  • Archives of dermatology
  • 2001 (First Publication: 1 May 2001)
  • OBJECTIVES To determine the safety and efficacy of oral bexarotene (Targretin capsules; Ligand Pharmaceuticals Incorporated, San Diego, Calif). DESIGN The effects of 2 randomized doses of 6.5Continue Reading